been on a drug called VASCEPA.... now put those same patients on Vascepa and plascebo 50% per cent each and have a study predicting 5.2% event rate... after 6 yrs because of more than 33000 patient years the event rate moves to 5%... now if the event rate has more placebo events and less Vascepa events the RRR exceeds 15%...
So relived to learn all " cardiovascular problems " appear the same ...All they need is Vascepa . . All we need are 8175 patients on statin therapy with CV problems ...doesn't seem to matter to you which CV problems . You sound like the previous Ceo Joe Z ...selling the trial. Kiwi
Market Data 
Markets 
AI
